fibrinogen has been researched along with Blood Coagulation Factor Deficiencies in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (65.38) | 29.6817 |
| 2010's | 8 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Era, S; Maeda, H; Matsunaga, S; Nakamura, E; Ono, Y; Seki, H; Takai, Y; Yamamoto, K | 1 |
| Banerjee, A; Cohen, MJ; Coleman, JR; Colvis, A; Ghasabyan, A; Moore, EE; Moore, HB; Nunns, GR; Sauaia, A; Silliman, CC; Stettler, GR | 1 |
| Chang, HJ; Choi, HS; Kim, BC; Kim, DY; Kim, SY; Oh, JH; Park, JW; Park, SC; Son, HJ | 1 |
| Adelmann, D; Illievich, UM; Klaus, DA; Kozek-Langenecker, S; Krall, C; Krenn, CG; Schaden, E | 1 |
| Ackroyd, S; Alikhan, R; Bowles, L; Chowdary, P; Grainger, J; Mainwaring, J; Mathias, M; Mumford, AD; O'Connell, N | 1 |
| Menegatti, M; Peyvandi, F | 1 |
| Weisel, JW | 1 |
| Dyr, JE; Hirmerová, J; Kotlín, R; Malý, M; Reicheltová, Z; Riedel, T; Salaj, P; Sobotková, A; Suttnar, J | 1 |
| Atkinson, JP; Hourcade, DE; Liszewski, MK | 1 |
| Kitchen, S; Woolley, A | 1 |
| Hamano, A; Madoiwa, KS; Matsuda, M; Mimuro, J; Sakata, Y; Sugo, T; Tanaka, T | 1 |
| Arocha-Piñango, CL; de Bosch, N; Marchi, R; Meyer, M; Soria, J; Weisel, JW | 1 |
| Cohen, BM; Cohen, E; Nielsen, VG | 1 |
| Castaman, G; Duga, S; Ghiotto, R; Rodeghiero, F | 1 |
| Benavides Márquez, F; Flor Serra, F; Peña Sendra, E; Rodríguez Cristóbal, JJ; Travé Mercadé, P; Villaverde Grote, C | 1 |
| Arana, C; Cutando-Soriano, A; Gómez-Moreno, G; Scully, C | 1 |
| Brimhall, B; Le, T; Sidhu, RS; Thompson, H | 1 |
| Al-Mondhiry, HA; Farrell, DH; Flood, VH | 1 |
| Dardik, R; Savion, N; Shenkman, B; Tamarin, I; Varon, D | 1 |
| Brooks, MB; Erb, HN; Stokol, T | 1 |
| Chan, JC | 1 |
| Sahud, M | 1 |
| Makris, M; Vora, A | 1 |
| Amadei, N; Baracho, GV; Bastos, W; Florido, MP; Isaac, L; Nudelman, V | 1 |
| Dechavanne, M; Ffrench, P; Hanss, M; Négrier, C; Sobas, F; Trzeciak, MC | 1 |
| Coller, BS; Gralnick, HR; Sultan, Y | 1 |
5 review(s) available for fibrinogen and Blood Coagulation Factor Deficiencies
| Article | Year |
|---|---|
Treatment of rare factor deficiencies in 2016.
Topics: Blood Coagulation Factors; Blood Component Transfusion; Coagulation Protein Disorders; Factor VIII; Fibrinogen; Humans; Plasma; Rare Diseases | 2016 |
Hereditary blood coagulation disorders: management and dental treatment.
Topics: Blood Coagulation Disorders, Inherited; Coagulation Protein Disorders; Dental Care for Chronically Ill; Fibrinogen; Hemostasis; Humans; Thrombosis | 2005 |
Gene targeting in hemostasis. tissue factor pathway inhibitor.
Topics: Animals; Animals, Newborn; Coagulation Protein Disorders; Factor VII; Factor VII Deficiency; Fibrinogen; Gene Expression; Gene Targeting; Hemostasis; Humans; Kidney; Lipoproteins; Liver; Mice; Phenotype; Serine Proteinase Inhibitors | 2001 |
Coagulation tests in differential diagnosis.
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Coagulation Protein Disorders; Diagnosis, Differential; Fibrinogen; Humans; Platelet Function Tests; Specimen Handling; von Willebrand Diseases | 2000 |
Personal practice: An approach to investigation of easy bruising.
Topics: Accidental Falls; Anti-Inflammatory Agents, Non-Steroidal; Child; Child Abuse; Child, Preschool; Coagulation Protein Disorders; Collagen Diseases; Contusions; Diagnosis, Differential; Fibrinogen; Humans; Infant; Infant, Newborn; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Prothrombin Time; Referral and Consultation; Thrombin Time; Thrombocytopenia; Vitamin K Deficiency Bleeding | 2001 |
2 trial(s) available for fibrinogen and Blood Coagulation Factor Deficiencies
| Article | Year |
|---|---|
Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
Topics: Anticoagulants; Automation; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Chromogenic Compounds; Coagulation Protein Disorders; Colorimetry; Drug Monitoring; Equipment Design; Fibrinogen; Heparin; High-Throughput Screening Assays; Humans; Indicators and Reagents; International Normalized Ratio; Nephelometry and Turbidimetry; Partial Thromboplastin Time; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Warfarin | 2013 |
[Randomised clinical trial of an intensive intervention into life-styles of patients with hyperfibrinogenaemia in primary prevention of cardiovascular pathology in primary health care].
Topics: Adult; Aged; Cardiovascular Diseases; Coagulation Protein Disorders; Female; Fibrinogen; Humans; Life Style; Male; Middle Aged; Primary Health Care; Risk Factors | 2005 |
19 other study(ies) available for fibrinogen and Blood Coagulation Factor Deficiencies
| Article | Year |
|---|---|
The Clinical Efficacy of Fibrinogen Concentrate in Massive Obstetric Haemorrhage with Hypofibrinogenaemia.
Topics: Adult; Coagulation Protein Disorders; Female; Fibrinogen; Hemorrhage; Humans; Pregnancy; Pregnancy Complications; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits.
Topics: Adolescent; Adult; Blood Coagulation Disorders; Blood Coagulation Factors; Case-Control Studies; Child; Coagulation Protein Disorders; Fibrinogen; Humans; International Normalized Ratio; Male; Partial Thromboplastin Time; Wounds and Injuries; Young Adult | 2019 |
Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer.
Topics: Biomarkers, Tumor; C-Reactive Protein; Carcinoembryonic Antigen; Coagulation Protein Disorders; Colonic Neoplasms; Female; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Multivariate Analysis; Neoplasm Grading; Neoplasm Staging; Postoperative Complications; Preoperative Care; Prognosis; Retrospective Studies; Survival Rate | 2013 |
Fibrinogen but not factor XIII deficiency is associated with bleeding after craniotomy.
Topics: Adolescent; Adult; Afibrinogenemia; Aged; Aged, 80 and over; Blood Coagulation Tests; Coagulation Protein Disorders; Confidence Intervals; Craniotomy; Factor XIII; Female; Fibrinogen; Humans; Male; Middle Aged; Neurosurgical Procedures; Odds Ratio; Partial Thromboplastin Time; Platelet Count; Postoperative Hemorrhage; Prospective Studies; ROC Curve; Young Adult | 2014 |
Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology.
Topics: Adult; Afibrinogenemia; Blood Coagulation Factors; Blood Coagulation Tests; Child; Coagulation Protein Disorders; Disease Management; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Male; Pregnancy; Pregnancy Complications, Hematologic; Recombinant Proteins | 2014 |
Why dysfibrinogenaemias still matter.
Topics: Blood Platelets; Coagulation Protein Disorders; Crystallography, X-Ray; Dimerization; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Heterozygote; Humans; Models, Genetic; Mutation; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding | 2009 |
Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
Topics: Adult; Blood Coagulation; Coagulation Protein Disorders; Female; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Mutation; Platelet Aggregation; Pulmonary Embolism; Thrombosis | 2009 |
Oversulfated heparin by-products induce thrombin generation in human plasmas through contact system activation.
Topics: Anaphylaxis; Anticoagulants; Blood Coagulation; Chondroitin Sulfates; Coagulation Protein Disorders; Disease Outbreaks; Drug Contamination; Enzyme Activation; Fibrinogen; Heparin; Humans; Kallikreins; Phosphatidylethanolamines; Prekallikrein; Prothrombin; Silicon Dioxide; Thrombin | 2010 |
Hypofibrinogenemia caused by a nonsense mutation in the fibrinogen Bbeta chain gene.
Topics: Aged; Coagulation Protein Disorders; Codon, Nonsense; Deoxyribonucleases, Type II Site-Specific; DNA Mutational Analysis; Female; Fibrinogen; Fibrinogens, Abnormal; Humans; Point Mutation | 2003 |
Biophysical characterization of fibrinogen Caracas I with an Aalpha-chain truncation at Aalpha-466 Ser: identification of the mutation and biophysical characterization of properties of clots from plasma and purified fibrinogen.
Topics: Biomechanical Phenomena; Blood Coagulation; Coagulation Protein Disorders; Codon, Nonsense; DNA Mutational Analysis; Family Health; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Humans; Microscopy, Electron, Scanning; Porosity; Sequence Deletion | 2004 |
Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Topics: Blood Coagulation; Blood Coagulation Factors; Coagulation Protein Disorders; Diatomaceous Earth; Dose-Response Relationship, Drug; Factor VII; Factor X; Factor XII; Fibrinogen; Humans; In Vitro Techniques; Kinetics; Plasma; Prothrombin; Thrombelastography; Thromboplastin | 2005 |
A novel fibrinogen gamma chain mutation (gamma 239 Gln-->His) is the cause of dysfibrinogenemia Vicenza.
Topics: Blood Coagulation Disorders, Inherited; Coagulation Protein Disorders; Fibrinogen; Fibrinogens, Abnormal; Humans; Mutation, Missense | 2005 |
Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1-6 degrees C for five days.
Topics: Adult; Blood Coagulation Factors; Blood Coagulation Tests; Blood Component Removal; Blood Preservation; Coagulation Protein Disorders; Cold Temperature; Fibrinogen; Humans; Plasma; Time Factors | 2006 |
The fibrinogen Aalpha R16C mutation results in fibrinolytic resistance.
Topics: Child, Preschool; Coagulation Protein Disorders; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Fibrinolysis; Heterozygote; Humans; Male; Mutation | 2006 |
Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor.
Topics: Afibrinogenemia; Coagulation Protein Disorders; Extracellular Matrix; Fibrinogen; Humans; Oligopeptides; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Polystyrenes; Solubility; Surface Properties; Thrombasthenia; von Willebrand Diseases; von Willebrand Factor | 2000 |
Effect of citrate concentration on coagulation test results in dogs.
Topics: Animals; Anticoagulants; Citric Acid; Coagulation Protein Disorders; Dog Diseases; Dogs; Factor IX; Factor VIII; Fibrinogen; Hemophilia A; Hemophilia B; Partial Thromboplastin Time; Prothrombin Time; von Willebrand Diseases | 2000 |
Inherited complete factor I deficiency associated with systemic lupus erythematosus, higher susceptibility to infection and low levels of factor H.
Topics: Adult; Bacterial Infections; Cell Migration Inhibition; Cells, Cultured; Child, Preschool; Coagulation Protein Disorders; Complement Activation; Complement C3; Complement C3b; Complement Factor H; Family Health; Female; Fibrinogen; Genetic Predisposition to Disease; Humans; Immunoelectrophoresis, Two-Dimensional; Lupus Erythematosus, Systemic; Phagocytosis | 2001 |
Human plasma fibrinogen measurement derived from activated partial thromboplastin time clot formation.
Topics: Adult; Aged; Anticoagulants; Blood Coagulation Tests; Coagulation Protein Disorders; Female; Fibrinogen; Humans; Immunoenzyme Techniques; Liver Diseases; Male; Middle Aged; Partial Thromboplastin Time; Predictive Value of Tests; Reproducibility of Results | 2002 |
Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
Topics: Antibodies; Antigens; Blood Coagulation Tests; Chemical Precipitation; Chromatography, Gel; Chymotrypsin; Coagulation Protein Disorders; Counterimmunoelectrophoresis; Electrophoresis, Polyacrylamide Gel; Female; Fibrinogen; Hemophilia A; Humans; Male; Platelet Adhesiveness; Platelet Aggregation; Ristocetin; von Willebrand Diseases | 1975 |